Prostate cancer
INACTIVE --- CRPC: treatment in daily clinical practiceAnthony (58 years old)
Anthony, a 58-year-old police officer, was diagnosed with multiple bone metastatic PCa (PSA 385 ng/ml) almost 3 years ago. He has no major comorbidities.
Course of the disease:
- Treatment with ADT + 6 cycles of docetaxel. His PSA 6 months after starting chemohormonal therapy was 2.1 ng/ml, ALP 31 U/l
- At 24 months post-ADT initiation:
- Increase in PSA to 24 ng/ml in 8 months
- Castrate testosterone level
- Bone scan: progression of bone metastases
- CT scan: 1 visceral metastasis (lung)
- Bone pain: requires paracetamol
- ECOG PS: 1
- Treatment for mCRPC was started with abiraterone:
- PSA: 4.1 ng/ml
- Bone metastases shrank by 20% (RECIST)
- Now, 9 months after starting abiraterone:
- PSA: 20 ng/ml, ALP: 185 U/l
- CT scan: radiographic progression of lymph nodes and lung metastasis (new)
- ECOG PS: 1
- No germline and/or somatic BRCA1/2 mutation identified